This is a reflection on the publication in Science Translational Medicine** which reports that HPBCD-treatment of murine atherosclerosis reduced atherosclerotic plaque size and cholesterol crystal load, improved cholesterol efflux and exerted anti-inflammatory effects.
*http://arstechnica.com/science/2016/04/sweet-drug-clears-cholesterol-reverses-heart-disease-and-was-found-by-parents/
**Zimmer et al. Sci Transl Med. 2016 Apr 6; 8(333):333ra50. DOI: 10.1126/scitranslmed.aad6100.
BACK TO NEWS